Immediate Impact

49 standout
Sub-graph 1 of 24

Citing Papers

Medical, surgical, and physical treatments for Parkinson's disease
2024 Standout
Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems
2023 Standout
3 intermediate papers

Works of Steven Schwid being referenced

Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: A multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon β-1a for relapsing multiple sclerosis
2007
Rasagiline-associated motor improvement in PD occurs without worsening of cognitive and behavioral symptoms
2006

Author Peers

Author Last Decade Papers Cites
Steven Schwid 247 219 23 85 10 417
J. Porcel 294 104 10 80 12 442
Howard Zwibel 418 140 18 63 11 495
Antonietta Citterio 215 225 16 43 13 444
V. Martinelli 318 155 20 29 10 445
Amer Awad 278 125 22 79 14 419
Kathryn A. Stolp‐Smith 250 198 19 64 12 494
Jamie Greenfield 228 88 31 62 20 443
S Olindo 352 273 9 121 10 449
Mathias Granqvist 189 191 29 37 13 492
Jürgen Koehler 165 123 10 48 13 408

All Works

Loading papers...

Rankless by CCL
2026